Benign prostatic syndrome. Urinary urgency and micturition frequency reduced with plant preparation
MMW Fortschritte der Medizin 147(40): 52-53
2005
ISSN/ISBN: 1438-3276 PMID: 16255520 Document Number: 592147
Document emailed within 1 workday
Related Documents
Kuo, H.C. 2001: Urodynamic results of intravesical heparin therapy for women with frequency urgency syndrome and interstitial cystitis Journal of the Formosan Medical Association 100(5): 309-314Kamalov, A.A.; Riaboĭ, A.V.; Ignashin, N.S.; Karpov, V.K.; Dorofeev, S.D. 2002: Use of proscar in preoperative preparation of patients with benign prostatic hyperplasia before transureteral resection Urologiia 2002(5): 16-18
Katsumi, T.; Murayama, K. 1992: Clinical effects of distigmine bromide (Ubretid), a cholinesterase inhibitor, on micturition disturbance by benign prostatic hypertrophy--comparative study of distigmine bromide and the combination of distigmine bromide and adrenergic blocker Hinyokika Kiyo. Acta Urologica Japonica 38(9): 1089-1092
Gossell-Williams, M.; Davis, A.; Aiken, W.; Mayhew, R. 2008: Herbal preparation use among patients with benign prostatic hyperplasia attending a urology clinic in Jamaica, West Indies West Indian Medical Journal 57(1): 75-76
Neĭmark, A.I.; Nozdrachev, N.A. 2013: Experience of the use of silodosin in acute urinary retention caused by benign prostatic hyperplasia Urologiia 4: 47-48; 50-51
Abrams, P. 1999: Evaluating lower urinary tract symptoms suggestive of benign prostatic obstruction Scandinavian Journal of Urology and Nephrology. Supplementum 203: 1-7
Haraguchi, C. 1989: Studies of the new parameter based on the urinary flow rate curve in benign prostatic hypertrophy Hinyokika Kiyo. Acta Urologica Japonica 35(1): 43-49
Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103
Neubauer, S. 2010: Benign prostatic syndrome (BPS) MMW Fortschritte der Medizin 152(23): 37-40
Li, Y.-Z.; Liang, W.-N.; Zhang, G.-W.; Weng, Z.-Q.; Zhong, Y.; Xu, S.; Shang, X.-J. 2019: Efficacy and safety of lycopene in the treatment of benign prostatic hyperplasia with lower urinary tract symptoms Zhonghua Nan Ke Xue 25(11): 1001-1004
Cornu, J-Nicolas.; Rouprêt, M. 2007: Impact of nocturia on the daily life of patients with lower urinary tract symptoms due to benign prostatic hyperplasia Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 17(5 Suppl 1: 1033-1036
Ben Rhouma, S.; H'sairi, M.; Adbi, H.; Binous, M.Y.; Nouira, Y.; Ben Raies, N.; Mosbah, A.T.; Horchani, A. 2015: Impact of alfuzosin 10 mg once daily on quality of life in Tunisian patients with lower urinary symptoms suggestive of benign prostatic hyperplasia La Tunisie Medicale 93(3): 164-169
Pytel', I.A.; Lopatkin, N.A.; Gorilovskiĭ, L.M.; Vinarov, A.Z.; Sivkov, A.V.; Medvedev, A.A. 2004: The results of long-term permixon treatment in patients with symptoms of lower urinary tracts dysfunction due to benign prostatic hyperplasia Urologiia 2: 3-7
Chen, Y.-G.; Liu, X.-Q. 2010: Interaction of metabolic syndrome and benign prostatic hyperplasia Zhonghua Nan Ke Xue 16(12): 1117-1119
Deng, Z.-X.; Ji, L.-X.; Zhang, Y.-R.; Li, C.-d.; Cai, J.; Jiang, H.-H. 2018: Ningmitai Capsules relieve lower urinary tract symptoms in patients with benign prostatic hyperplasia : a short-term clinical observation Zhonghua Nan Ke Xue 24(1): 72-77
Kongkanand, A.; Chodchoy, V.; Lojanapiwat, B.; Pumpaisanchai, S.; Ratana-Olarn, K.; Sae-Tang, P.; Taweemonkongsap, T. 2009: Safety and efficacy of a prolonged-release formulation of alfuzosin 10 mg once daily in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia Journal of the Medical Association of Thailand 92(7): 969-978
Kupriyanov, Y.A.; Rasner, P.I.; Rokhlikov, I.M.; Akrikidi, A.A.; Soloviev, V.V.; Markov, A.A.; Nozdrin, E.V.; Logvinov, L.A.; Vasilevskiy, R.P.; Skrupskiy, K.S.; Pushkar, D.Y.; Putilovskiy, M.A.; Epstein, O.I. 2019: The experience of using drug Afalaza for treatment of lower urinary symptoms in treatment-nave patients with benign prostatic hyperplasia Urologiia 3: 36-42
Tyuzikov, I.A.; Grekov, E.A.; Kalinchenko, S.Y. 2015: Features of Clinical Course and Morphometric Parameters of Benign Prostatic Hyperplasia in Men with Metabolic Syndrome and Androgen Deficiency Urologiia 5: 66-69
Jonas, U.; Melchior, H.; Rübben, H. 1998: Recommendations for billing alternative therapy of benign prostatic hyperplasia. Laser therapy of benign prostatic hyperplasia Der Urologe. Ausg. a 37(1): 110-111
Willington, F.L. 1978: Urinary incontinence and urgency Practitioner 220(1319): 739-747